Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model

Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone (New York, N.Y.) N.Y.), 2009-05, Vol.44, p.S164-S164
Hauptverfasser: Labrinidis, A, Liapis, V, Hay, S, Findlay, D.M, Evdokiou, A
Format: Artikel
Sprache:eng
Schlagworte:
Orthopedics
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S164
container_issue
container_start_page S164
container_title Bone (New York, N.Y.)
container_volume 44
creator Labrinidis, A
Liapis, V
Hay, S
Findlay, D.M
Evdokiou, A
description
doi_str_mv 10.1016/j.bone.2009.01.383
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20477697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S8756328209004104</els_id><sourcerecordid>20477697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1827-75fffe52470bd9dfef3c0522ba49bc5046482f580aba1f3ad4fa4ad88be3c1643</originalsourceid><addsrcrecordid>eNp9kc2u1SAUhRujicerL-CoI2etm58WmhgTc-NfcpM7UCdOCIVNDkcKR-gxOe_iw0qtIwd3RFistWDzNc1LAj0BMr4-9XOK2FOAqQfSM8keNQciBeuoGNnj5iDFMHaMSvq0eVbKCQDYJMih-f09BbQ5RW9abbxtfTz62a-lndN6bNcjtqmsmMJ13RzR7ts56LIJJi3nenGs_uT2o6JzVXUbsPgUSy3cq3Rs_bJcYrLovPE187du17YeXHfNLzq0S7WF580Tp0PBF__Wm-bbh_dfbz91d_cfP9--u-sMkVR0YnDO4UC5gNlO1qFjBgZKZ82n2QzARy6pGyToWRPHtOVOc22lnJEZMnJ207zae885_bxgWdXii8EQdMR0KYoCF2KcRDXS3WhyKiWjU-dcn5uvioDaQKiT2kCoDYQCoiqIGnqzh7CO8MtjVmUb36D1Gc2qbPIPx9_-FzfBV1w6_MArllO65Fg_RxFVqAL1ZSO9gYYJgBPg7A-kkaw3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20477697</pqid></control><display><type>article</type><title>Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model</title><source>Access via ScienceDirect (Elsevier)</source><creator>Labrinidis, A ; Liapis, V ; Hay, S ; Findlay, D.M ; Evdokiou, A</creator><creatorcontrib>Labrinidis, A ; Liapis, V ; Hay, S ; Findlay, D.M ; Evdokiou, A</creatorcontrib><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2009.01.383</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Orthopedics</subject><ispartof>Bone (New York, N.Y.), 2009-05, Vol.44, p.S164-S164</ispartof><rights>2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bone.2009.01.383$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Labrinidis, A</creatorcontrib><creatorcontrib>Liapis, V</creatorcontrib><creatorcontrib>Hay, S</creatorcontrib><creatorcontrib>Findlay, D.M</creatorcontrib><creatorcontrib>Evdokiou, A</creatorcontrib><title>Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model</title><title>Bone (New York, N.Y.)</title><subject>Orthopedics</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kc2u1SAUhRujicerL-CoI2etm58WmhgTc-NfcpM7UCdOCIVNDkcKR-gxOe_iw0qtIwd3RFistWDzNc1LAj0BMr4-9XOK2FOAqQfSM8keNQciBeuoGNnj5iDFMHaMSvq0eVbKCQDYJMih-f09BbQ5RW9abbxtfTz62a-lndN6bNcjtqmsmMJ13RzR7ts56LIJJi3nenGs_uT2o6JzVXUbsPgUSy3cq3Rs_bJcYrLovPE187du17YeXHfNLzq0S7WF580Tp0PBF__Wm-bbh_dfbz91d_cfP9--u-sMkVR0YnDO4UC5gNlO1qFjBgZKZ82n2QzARy6pGyToWRPHtOVOc22lnJEZMnJ207zae885_bxgWdXii8EQdMR0KYoCF2KcRDXS3WhyKiWjU-dcn5uvioDaQKiT2kCoDYQCoiqIGnqzh7CO8MtjVmUb36D1Gc2qbPIPx9_-FzfBV1w6_MArllO65Fg_RxFVqAL1ZSO9gYYJgBPg7A-kkaw3</recordid><startdate>20090501</startdate><enddate>20090501</enddate><creator>Labrinidis, A</creator><creator>Liapis, V</creator><creator>Hay, S</creator><creator>Findlay, D.M</creator><creator>Evdokiou, A</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope></search><sort><creationdate>20090501</creationdate><title>Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model</title><author>Labrinidis, A ; Liapis, V ; Hay, S ; Findlay, D.M ; Evdokiou, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1827-75fffe52470bd9dfef3c0522ba49bc5046482f580aba1f3ad4fa4ad88be3c1643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Orthopedics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Labrinidis, A</creatorcontrib><creatorcontrib>Liapis, V</creatorcontrib><creatorcontrib>Hay, S</creatorcontrib><creatorcontrib>Findlay, D.M</creatorcontrib><creatorcontrib>Evdokiou, A</creatorcontrib><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Labrinidis, A</au><au>Liapis, V</au><au>Hay, S</au><au>Findlay, D.M</au><au>Evdokiou, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model</atitle><jtitle>Bone (New York, N.Y.)</jtitle><date>2009-05-01</date><risdate>2009</risdate><volume>44</volume><spage>S164</spage><epage>S164</epage><pages>S164-S164</pages><issn>8756-3282</issn><eissn>1873-2763</eissn><pub>Elsevier Inc</pub><doi>10.1016/j.bone.2009.01.383</doi></addata></record>
fulltext fulltext
identifier ISSN: 8756-3282
ispartof Bone (New York, N.Y.), 2009-05, Vol.44, p.S164-S164
issn 8756-3282
1873-2763
language eng
recordid cdi_proquest_miscellaneous_20477697
source Access via ScienceDirect (Elsevier)
subjects Orthopedics
title Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A16%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zoledronic%20acid%20inhibits%20both%20the%20osteolytic%20and%20osteoblastic%20components%20of%20osteosarcoma%20lesions%20in%20both%20an%20immunodeficient%20and%20immunocompetent%20animal%20model&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Labrinidis,%20A&rft.date=2009-05-01&rft.volume=44&rft.spage=S164&rft.epage=S164&rft.pages=S164-S164&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2009.01.383&rft_dat=%3Cproquest_cross%3E20477697%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20477697&rft_id=info:pmid/&rft_els_id=S8756328209004104&rfr_iscdi=true